Does rs1049174 in KLRK1 alter NKG2D expression and NK cell cytotoxicity?

The KLRK1 gene plays a central role in human immunosurveillance by encoding the NKG2D activating receptor, a critical component for natural killer (NK) cell recognition of stressed, infected, or malignant cells. Research confirms that common genetic variations within this gene, specifically the rs1049174 single nucleotide polymorphism (SNP), significantly dictate individual differences in immune receptor density and subsequent cytotoxic potency.

Impact on receptor expression

The rs1049174 SNP is a primary determinant of NKG2D surface density. Evidence distinguishes two major functional phenotypes: the "Low NKG2D" (LNK) phenotype, typically associated with the T allele, and the "High NKG2D" (HNK) phenotype, associated with the C/G allele. Flow cytometry analysis indicates that individuals carrying the LNK-associated allele exhibit a 50-70% reduction in NKG2D surface density compared to those with the HNK variant. This reduction is particularly pronounced in the CD56bright NK cell subset, where mean fluorescence intensity (MFI) significantly varies by genotype.

Mechanistic basis of modulation

The variation in expression is driven by a post-transcriptional regulatory mechanism involving microRNA interference. The T allele of rs1049174 creates a highly efficient binding site for miR-124-5p within the KLRK1 transcript. This binding leads to targeted translational suppression, effectively lowering the amount of NKG2D protein that reaches the cell surface despite stable mRNA levels.

Effects on NK cell cytotoxicity

Alterations in receptor density translate directly into functional immune differences. Carriers of the G/C (HNK) variant demonstrate significantly enhanced NK cell degranulation and higher accumulation of granzyme B, an essential effector protease for inducing apoptosis in target cells. In clinical settings, such as acute myeloid leukemia (AML), these "high-cytotoxicity" genotypes are associated with superior leukemia-free and overall survival rates due to more robust NKG2D-dependent tumor cell killing.

Bottom line

KLRK1 encodes the essential NKG2D receptor, and the rs1049174 polymorphism acts as a functional switch that modulates receptor levels via miR-124-5p interference, directly influencing NK cell cytotoxic efficiency and clinical outcomes in immune-mediated diseases.